Black Friday saleUp to 70% OFF
444

SYNCORE BIOTECHNOL

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

4192 chart


Full chart

Key stats


Market capitalization
‪1.24 B‬ TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
3,432.70
Basic EPS (TTM)
0.00 TWD
Net income (FY)
‪−38.17 M‬ TWD
Revenue (FY)
‪20.20 M‬ TWD
Shares float
‪18.18 M‬
Beta (1Y)
0.30

About SYNCORE BIOTECHNOL


Sector
Health Technology
CEO
Mu Huan Su
Headquarters
Yilan
Website
syncorebio.com
Founded
2008
ISIN
TW0004192000
FIGI
BBG00553G5T6
SynCore Biotechnology Co., Ltd. is a biopharmaceutical company. It engages in the business of new drug developing and selling, food advisory, medicine inspection, biotechnology service, and intellectual property. The company was founded by Chih Wen Li on June 26, 2008 and is headquartered in Yilan, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4192 is 36.40 TWD — it has increased by 1.68% in the past 24 hours. Watch SYNCORE BIOTECHNOL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange SYNCORE BIOTECHNOL stocks are traded under the ticker 4192.
4192 stock has fallen by −1.89% compared to the previous week, the month change is a −2.68% fall, over the last year SYNCORE BIOTECHNOL has showed a 3.56% increase.
4192 reached its all-time high on Jul 10, 2020 with the price of 571.15 TWD, and its all-time low was 34.55 TWD and was reached on Mar 11, 2024. View more price dynamics on 4192 chart.
See other stocks reaching their highest and lowest prices.
4192 stock is 0.55% volatile and has beta coefficient of 0.30. Track SYNCORE BIOTECHNOL stock price on the chart and check out the list of the most volatile stocks — is SYNCORE BIOTECHNOL there?
Today SYNCORE BIOTECHNOL has the market capitalization of ‪1.24 B‬, it has decreased by −2.59% over the last week.
Yes, you can track SYNCORE BIOTECHNOL financials in yearly and quarterly reports right on TradingView.
4192 net income for the last quarter is ‪−14.38 M‬ TWD, while the quarter before that showed ‪−13.50 M‬ TWD of net income which accounts for −6.59% change. Track more SYNCORE BIOTECHNOL financial stats to get the full picture.
No, 4192 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNCORE BIOTECHNOL EBITDA is ‪−43.61 M‬ TWD, and current EBITDA margin is −127.95%. See more stats in SYNCORE BIOTECHNOL financial statements.
Like other stocks, 4192 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNCORE BIOTECHNOL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNCORE BIOTECHNOL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNCORE BIOTECHNOL stock shows the sell signal. See more of SYNCORE BIOTECHNOL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.